We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$53.7B
AUM Growth
-$2.95B
Cap. Flow
+$168M
Cap. Flow %
0.31%
Top 10 Hldgs %
35.03%
Holding
1,742
New
57
Increased
475
Reduced
481
Closed
34

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$234M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$120M
3
MU icon
Micron Technology
MU
+$114M
4
CSGP icon
CoStar Group
CSGP
+$112M
5
LIN icon
Linde
LIN
+$103M

Top Sells

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$421M
2
ABBV icon
AbbVie
ABBV
+$174M
3
TMO icon
Thermo Fisher Scientific
TMO
+$126M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$107M
5
COF icon
Capital One
COF
+$84.2M

Sector Composition

Rank Sector Weight
1 Technology 31.44%
2 Financials 12.06%
3 Healthcare 11.81%
4 Communication Services 9.87%
5 Consumer Discretionary 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DG icon
276
Dollar General
DG
$27.5B
$23.9M 0.04%
201,462
+25,407
+14% +$3.62M
AIG icon
277
American International
AIG
$42.5B
$23.9M 0.04%
317,746
-150,179
-32% -$11.5M
NBIX icon
278
Neurocrine Biosciences
NBIX
$17.4B
$23.9M 0.04%
181,481
+14,174
+8% +$1.88M
FTV icon
279
Fortive
FTV
$18.6B
$23.9M 0.04%
431,633
-96,706
-18% -$5.42M
NI icon
280
NiSource
NI
$21.8B
$23.5M 0.04%
503,652
+7,158
+1% +$322K
TARS icon
281
Tarsus Pharmaceuticals
TARS
$2.45B
$23.4M 0.04%
332,982
-141,068
-30% -$9.86M
IDXX icon
282
Idexx Laboratories
IDXX
$44.5B
$23.2M 0.04%
41,370
-8,325
-17% -$5.34M
DD icon
283
DuPont de Nemours
DD
$18.3B
$23.2M 0.04%
168,854
+33,362
+25% +$4.6M
SNDX icon
284
Syndax Pharmaceuticals
SNDX
$1.98B
$23.1M 0.04%
990,969
-607,575
-38% -$13.2M
ALNY icon
285
Alnylam Pharmaceuticals
ALNY
$36.4B
$23M 0.04%
69,647
+11,715
+20% +$3.99M
IQV icon
286
IQVIA
IQV
$34B
$22.9M 0.04%
134,401
+84,503
+169% +$16.5M
DXCM icon
287
DexCom
DXCM
$29.2B
$22.8M 0.04%
362,712
-336,435
-48% -$23.4M
STLD icon
288
Steel Dynamics
STLD
$33.2B
$22.6M 0.04%
125,742
-25,830
-17% -$4.7M
USFD icon
289
US Foods
USFD
$20.9B
$22.2M 0.04%
241,189
-382,656
-61% -$33.9M
RVMD icon
290
Revolution Medicines
RVMD
$38.4B
$22.2M 0.04%
227,940
-7,868
-3% -$794K
COGT icon
291
Cogent Biosciences
COGT
$6.77B
$22M 0.04%
572,872
+151,332
+36% +$5.59M
PRAX icon
292
Praxis Precision Medicines
PRAX
$8.49B
$22M 0.04%
68,383
+4,100
+6% +$1.27M
LPLA icon
293
LPL Financial
LPLA
$26.2B
$21.9M 0.04%
72,862
-37,016
-34% -$12.4M
CMS icon
294
CMS Energy
CMS
$22.5B
$21.6M 0.04%
278,477
-25,780
-8% -$1.91M
LW icon
295
Lamb Weston
LW
$6.43B
$21.5M 0.04%
508,639
+323,704
+175% +$14.4M
INCY icon
296
Incyte
INCY
$23.1B
$21.4M 0.04%
227,612
-23,283
-9% -$2.32M
TVTX icon
297
Travere Therapeutics
TVTX
$5.26B
$21.3M 0.04%
715,707
-89,508
-11% -$2.68M
WDAY icon
298
Workday
WDAY
$36.4B
$21.2M 0.04%
163,050
+101,447
+165% +$16.1M
MRVL icon
299
Marvell Technology
MRVL
$187B
$20.9M 0.04%
211,254
+56,027
+36% +$4.71M
ULTA icon
300
Ulta Beauty
ULTA
$21B
$20.7M 0.04%
39,686
+3,887
+11% +$2.47M
10 11
12
13 14

Similar funds

Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
State Board of Administration of Florida Retirement System
State Board of Administration of Florida Retirement System Tallahassee, Florida $53.4B AUM 29.16% 1-Year Est. Return
Betterment LLC
Betterment LLC New York $52.8B AUM 15.34% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SCP
Soroban Capital Partners New York $51.8B AUM 21.41% 1-Year Est. Return

Ensign Peak Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Ensign Peak Advisors held 1,742 positions worth $53.7B, down 5.2% from $56.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ensign Peak Advisors's Q1 2026 filing shows 57 new, 475 increased, 481 reduced and 34 closed positions. Its largest new stake was Novo Nordisk: 400,384 shares worth $14.7M. The largest sale was FTAI Aviation, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

  • Ensign Peak Advisors's largest Q1 2026 buy was Novo Nordisk: 400,384 shares worth $14.7M.
  • Ensign Peak Advisors added most to Boston Scientific in Q1 2026, an estimated $234M increase.
  • Ensign Peak Advisors's biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $421M.
  • Ensign Peak Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $17M.
  • Ensign Peak Advisors's ten largest holdings make up 35% of its $53.7B portfolio in Q1 2026.
  • Ensign Peak Advisors opened 57 new positions and closed 34 in Q1 2026.
  • Ensign Peak Advisors's portfolio value fell 5.2% quarter-over-quarter to $53.7B.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.